These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15988802)

  • 1. Interest groups' influence over drug pricing policy reform in South Korea.
    Chung WJ; Kim HJ
    Yonsei Med J; 2005 Jun; 46(3):321-30. PubMed ID: 15988802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from Korea's pharmaceutical policy reform: the separation of medical institutions and pharmacies for outpatient care.
    Kim HJ; Chung W; Lee SG
    Health Policy; 2004 Jun; 68(3):267-75. PubMed ID: 15113638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance.
    Yang BM; Bae EY; Kim J
    Health Aff (Millwood); 2008; 27(1):179-87. PubMed ID: 18180493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing process and politics of health policy in Korea.
    Kwon S; Reich MR
    J Health Polit Policy Law; 2005 Dec; 30(6):1003-26. PubMed ID: 16481306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical reform in South Korea and the lessons it provides.
    Kim HJ; Ruger JP
    Health Aff (Millwood); 2008; 27(4):w260-9. PubMed ID: 18508813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs.
    Kwon HY; Kim H; Godman B; Reich MR
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):1007-14. PubMed ID: 26394767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vice into virtue? Progressive politics and welfare reform in continental Europe.
    Levy JD
    Polit Soc; 1999; 27(2):239-73. PubMed ID: 22053415
    [No Abstract]   [Full Text] [Related]  

  • 8. Health for all in the Republic of Korea: one country's experience with implementing universal health care.
    Peabody JW; Lee SW; Bickel SR
    Health Policy; 1995 Jan; 31(1):29-42. PubMed ID: 10140361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actor management in the development of health financing reform: health insurance in South Africa, 1994-1999.
    Thomas S; Gilson L
    Health Policy Plan; 2004 Sep; 19(5):279-91. PubMed ID: 15310663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delisting policy reform in South Korea: failed or policy change?
    Lee H; Kim J
    Value Health; 2012 Jan; 15(1):204-12. PubMed ID: 22264990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy context of the poor progress of the pro-poor policy: a case study on the Medical-Aid policy during Kim Dae-jung's government (1998-2002) in the Republic of Korea.
    Shin YJ
    Health Policy; 2006 Oct; 78(2-3):209-23. PubMed ID: 16289428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To whom do bureaucrats need to respond? Two faces of civil society in health policy.
    Lim S; Lee KH; Suh HS; Bae KH
    Soc Sci Med; 2014 Dec; 123():269-77. PubMed ID: 25459209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reform regulations now come blow after blow. However physicians must still wait for fixed point values].
    MMW Fortschr Med; 2006 Feb; 148(7):48-9. PubMed ID: 16529364
    [No Abstract]   [Full Text] [Related]  

  • 14. Health care reform in South Korea: success or failure?
    Lee JC
    Am J Public Health; 2003 Jan; 93(1):48-51. PubMed ID: 12511383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New cost saving legislation for drugs. National health insurance carriers do not want to believe Ulla Schmidt}].
    MMW Fortschr Med; 2006 Feb; 148(5):45. PubMed ID: 16518939
    [No Abstract]   [Full Text] [Related]  

  • 16. Knowledge-based changes to health systems: the Thai experience in policy development.
    Tangcharoensathien V; Wibulpholprasert S; Nitayaramphong S
    Bull World Health Organ; 2004 Oct; 82(10):750-6. PubMed ID: 15643796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New institute for additional drug evaluation. Do we really need another barrier?].
    Schmidt K
    MMW Fortschr Med; 2003 Jul; 145(29-30):55-6. PubMed ID: 12958781
    [No Abstract]   [Full Text] [Related]  

  • 18. Federalism and the Patient Protection and Affordable Care Act of 2010: the Founding Fathers would not be surprised.
    Sparer MS
    J Health Polit Policy Law; 2011 Jun; 36(3):461-8. PubMed ID: 21673246
    [No Abstract]   [Full Text] [Related]  

  • 19. Health, health care, and incompletely theorized agreements: a normative theory of health policy decision making.
    Ruger JP
    J Health Polit Policy Law; 2007 Feb; 32(1):51-87. PubMed ID: 17312325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Between credit claiming and blame avoidance: the changing politics of priority-setting for Korea's National Health Insurance System.
    Kang M; Reich MR
    Health Policy; 2014 Mar; 115(1):9-17. PubMed ID: 24176287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.